Cognitive & Neuro
SLU-PP-332 — ERR agonist mimicking exercise at the mitochondrial level.
SLU-PP-332 is a pan-agonist of estrogen-related receptors (ERRα/β/γ), the transcription factors that drive oxidative metabolism and mitochondrial biogenesis in muscle. Preclinical work shows it reproduces many endurance-training adaptations without exercise.
Each PeptidePen is filled in a controlled cleanroom and sealed with tamper-evident packaging. Batch documentation includes identity confirmation, HPLC purity analysis and concentration verification. Strictly for in-vitro research — not for human or veterinary use.
A full breakdown of mechanism, clinical findings, dosing references and safety signals — for researchers who want the complete picture.
SLU-PP-332 is an experimental peptide studied for its potential interaction with metabolic and energy-related processes at the cellular level. It is classified as a Positive Allosteric Modulator (PAM), with research focusing on its interaction with natural regulatory pathways involved in energy utilization, physical endurance, and oxidative metabolism.
This next-generation bioactive compound is primarily explored in controlled research settings related to cellular adaptation, mitochondrial efficiency, and recovery following physical stress.
SLU-PP-332 is being investigated for its role in:
Supporting cellular energy regulation
Enhancing mitochondrial efficiency
Contributing to adaptive responses under metabolic stress
Supporting physical endurance pathways
It is associated with mechanisms that resemble physiological responses observed during exercise and metabolic adaptation.
Scientific interest in SLU-PP-332 is driven by its potential to support:
Energy metabolism, particularly in skeletal muscle
Physical endurance and resistance to fatigue
Glucose utilization and fatty acid oxidation pathways
Cellular adaptation to metabolic stress
Mitochondrial activity without overstimulation of cardiovascular parameters
Preclinical observations suggest that it may support more efficient energy use and recovery processes without signs of excessive stimulation.
SLU-PP-332 is currently in a preclinical research phase.
Available data from experimental models indicate potential associations with:
Increased aerobic capacity (including VO₂ max-related parameters)
Enhanced mitochondrial function in muscle tissue
Improved tolerance to intensive physical activity
Activation of metabolic pathways similar to those observed during training
These findings are preliminary and require further validation in clinical settings.
Usage may vary depending on individual protocols and research objectives. A commonly referenced approach:
7–10 units, twice daily
Morning: 7–10 units
Afternoon: 7–10 units
For individuals below 55 kg, a lower range (e.g., 7 units twice daily) is often considered.
The dosing system allows precise adjustment via a rotating dial, where each unit corresponds to a defined increment.
Application is typically performed in areas such as the abdominal region or upper leg. It is recommended to wait approximately 10 seconds after delivery before removing the device from the skin. Rotation of application areas is advised.
Up to 1 month of use
Followed by 15 days pause
1 pen = 300 units
Each unit contains 5 mcg SLU-PP-332
Total content: 1.5 mg per pen
1 unit = 5 mcg
5 units = 25 mcg
10 units = 50 mcg
No significant adverse effects have been reported in preclinical observations to date. Potential responses may include:
Temporary fatigue or mild headache at higher ranges
Local skin sensitivity
Changes in appetite or perceived energy levels
As with all peptides, responses may vary depending on dosage, duration, and individual sensitivity. Combining with other stimulating compounds is not recommended without a clear scientific rationale.
Increases mitochondrial biogenesis (PGC-1α pathway)
Improves endurance in rodent models (+70%)
Reduces adiposity without caloric restriction
Upregulates fat oxidation gene programs
Form
Pre-mixed pen
Purity
≥99% HPLC
Storage
2–8°C
Shipping
Cold-chain
COA
Batch-matched
Select pen size and shipping region at checkout.
Each batch is HPLC-assayed and documented.
Insulated, temperature-logged delivery.
Reference dosing and references included.
Common questions about SLU-PP-332 and PeptidePen orders.
No. All PeptidePen products are strictly for in-vitro laboratory research. Not intended for human or veterinary use.
Each pen ships with a batch-matched certificate of analysis. A digital copy is also available on request via your order confirmation.
Orders ship cold-chain (2–8°C) with insulated packaging, ice packs and a temperature log. Tracked delivery in the US and EU.
Yes. Contact our team for institutional pricing, custom concentrations and recurring shipments.
Damaged or off-spec pens are replaced free of charge. Contact support within 7 days of delivery.
Pre-mixed, batch-assayed, cold-chain shipped — order before 2pm for same-day dispatch.
